87 related articles for article (PubMed ID: 12193060)
1. HMG-CoA reductase inhibition and PPAR- alpha activation both inhibit cyclosporin A induced endothelin-1 secretion in cultured endothelial cells.
Kandoussi A; Martin F; Hazzan M; Noël C; Fruchart JC; Staels B; Duriez P
Clin Sci (Lond); 2002 Aug; 103 Suppl 48():81S-83S. PubMed ID: 12193060
[TBL] [Abstract][Full Text] [Related]
2. Differential sensitivity of various pediatric cancers and squamous cell carcinomas to lovastatin-induced apoptosis: therapeutic implications.
Dimitroulakos J; Ye LY; Benzaquen M; Moore MJ; Kamel-Reid S; Freedman MH; Yeger H; Penn LZ
Clin Cancer Res; 2001 Jan; 7(1):158-67. PubMed ID: 11205904
[TBL] [Abstract][Full Text] [Related]
3. Differential effects of different statins on endothelin-1 gene expression and endothelial NOS phosphorylation in porcine aortic endothelial cells.
Ohkita M; Sugii M; Ka Y; Kitamura A; Mori T; Hayashi T; Takaoka M; Matsumura Y
Exp Biol Med (Maywood); 2006 Jun; 231(6):772-6. PubMed ID: 16740997
[TBL] [Abstract][Full Text] [Related]
4. HMG-CoA reductase inhibition reduces the proinflammatory activation of human vascular smooth muscle cells by the terminal complement factor C5b-9.
Viedt C; Shen W; Fei J; Kamimura M; Hänsch GM; Katus HA; Kreuzer J
Basic Res Cardiol; 2003 Nov; 98(6):353-61. PubMed ID: 14556080
[TBL] [Abstract][Full Text] [Related]
5. Statins inhibit secretion of metalloproteinases-1, -2, -3, and -9 from vascular smooth muscle cells and macrophages.
Luan Z; Chase AJ; Newby AC
Arterioscler Thromb Vasc Biol; 2003 May; 23(5):769-75. PubMed ID: 12663370
[TBL] [Abstract][Full Text] [Related]
6. Endothelin-1-induced cardiac hypertrophy is inhibited by activation of peroxisome proliferator-activated receptor-alpha partly via blockade of c-Jun NH2-terminal kinase pathway.
Irukayama-Tomobe Y; Miyauchi T; Sakai S; Kasuya Y; Ogata T; Takanashi M; Iemitsu M; Sudo T; Goto K; Yamaguchi I
Circulation; 2004 Feb; 109(7):904-10. PubMed ID: 14967736
[TBL] [Abstract][Full Text] [Related]
7. Tocotrienols potentiate lovastatin-mediated growth suppression in vitro and in vivo.
McAnally JA; Gupta J; Sodhani S; Bravo L; Mo H
Exp Biol Med (Maywood); 2007 Apr; 232(4):523-31. PubMed ID: 17392488
[TBL] [Abstract][Full Text] [Related]
8. Stimulation of peroxisome-proliferator-activated receptor alpha (PPAR alpha) attenuates cardiac fibrosis and endothelin-1 production in pressure-overloaded rat hearts.
Ogata T; Miyauchi T; Sakai S; Irukayama-Tomobe Y; Goto K; Yamaguchi I
Clin Sci (Lond); 2002 Aug; 103 Suppl 48():284S-288S. PubMed ID: 12193105
[TBL] [Abstract][Full Text] [Related]
9. HMG-CoA reductase inhibition reduces monocyte CC chemokine receptor 2 expression and monocyte chemoattractant protein-1-mediated monocyte recruitment in vivo.
Han KH; Ryu J; Hong KH; Ko J; Pak YK; Kim JB; Park SW; Kim JJ
Circulation; 2005 Mar; 111(11):1439-47. PubMed ID: 15781755
[TBL] [Abstract][Full Text] [Related]
10. High-dose lovastatin decreased basal prostacyclin production in cultured endothelial cells.
Zhou Q; Zhou Y; Kummerow FA
Prostaglandins Other Lipid Mediat; 2009 Jun; 89(1-2):1-7. PubMed ID: 19135546
[TBL] [Abstract][Full Text] [Related]
11. Statins (HMG-CoA reductase inhibitors) reduce CD40 expression in human vascular cells.
Mulhaupt F; Matter CM; Kwak BR; Pelli G; Veillard NR; Burger F; Graber P; Lüscher TF; Mach F
Cardiovasc Res; 2003 Sep; 59(3):755-66. PubMed ID: 14499877
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of the class II HMG-CoA reductase of Pseudomonas mevalonii.
Hedl M; Rodwell VW
Protein Sci; 2004 Jun; 13(6):1693-7. PubMed ID: 15152097
[TBL] [Abstract][Full Text] [Related]
13. Lovastatin inhibits oxidized low-density lipoprotein-induced plasminogen activator inhibitor and transforming growth factor-beta1 expression via a decrease in Ras/extracellular signal-regulated kinase activity in mesangial cells.
Song CY; Kim BC; Lee HS
Transl Res; 2008 Jan; 151(1):27-35. PubMed ID: 18061125
[TBL] [Abstract][Full Text] [Related]
14. Statins rise cytoplasmic calcium level [Ca2+]i in cultured endothelial cells.
Lorkowska B; Chlopicki S; Marcinkiewicz E; Gryglewski RJ
Pol J Pharmacol; 2004; 56(3):313-8. PubMed ID: 15215561
[TBL] [Abstract][Full Text] [Related]
15. Simvastatin modulates TNFalpha-induced adhesion molecules expression in human endothelial cells.
Zapolska-Downar D; Siennicka A; Kaczmarczyk M; Kołodziej B; Naruszewicz M
Life Sci; 2004 Jul; 75(11):1287-302. PubMed ID: 15234187
[TBL] [Abstract][Full Text] [Related]
16. Isoprenoid depletion by statins antagonizes cytokine-induced down-regulation of endothelial nitric oxide expression and increases NO synthase activity in human umbilical vein endothelial cells.
Jantzen F; Könemann S; Wolff B; Barth S; Staudt A; Kroemer HK; Dahm JB; Felix SB; Landsberger M
J Physiol Pharmacol; 2007 Sep; 58(3):503-14. PubMed ID: 17928646
[TBL] [Abstract][Full Text] [Related]
17. Antioxidant effects of statins via S-nitrosylation and activation of thioredoxin in endothelial cells: a novel vasculoprotective function of statins.
Haendeler J; Hoffmann J; Zeiher AM; Dimmeler S
Circulation; 2004 Aug; 110(7):856-61. PubMed ID: 15289372
[TBL] [Abstract][Full Text] [Related]
18. Hypothesis: the antitumor activities of statins may be mediated by IL-18.
Takahashi HK; Weitz-Schmidt G; Iwagaki H; Yoshino T; Tanaka N; Nishibori M
J Leukoc Biol; 2006 Aug; 80(2):215-6. PubMed ID: 16735695
[TBL] [Abstract][Full Text] [Related]
19. HMG-CoA reductase inhibitor fluvastatin prevents angiotensin II-induced cardiac hypertrophy via Rho kinase and inhibition of cyclin D1.
Morikawa-Futamatsu K; Adachi S; Maejima Y; Tamamori-Adachi M; Suzuki J; Kitajima S; Ito H; Isobe M
Life Sci; 2006 Aug; 79(14):1380-90. PubMed ID: 16712874
[TBL] [Abstract][Full Text] [Related]
20. Simvastatin inhibits C-reactive protein-induced pro-inflammatory changes in endothelial cells by decreasing mevalonate pathway products.
Liang YJ; Shyu KG; Wang BW; Lai LP
Cardiology; 2008; 110(3):182-90. PubMed ID: 18057884
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
